1. Hormonal medication in medically assisted reproduction: a systematic review of assessments from patients 
Kay Lankreijer, Thomas M D'Hooghe, Silke Apers, Walter Sermeus, Sjoerd Repping, Eline AF Dancet 
Reproductive BioMedicine Online 
Volume 38, Issue 3, Pages (March 2019)
DOI: /j.rbmo
Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1 Search strategy.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

3. Figure 2
The seven medication characteristics valued by patients. These characteristics were derived from the conceptual framework for the impact of controlled ovarian stimulation of Brod and Fennema (2013) and adapted based on patient interviews concerning experiences with hormonal fertility medications from all medication phases and routes of administration (Lankreijer et al., 2016).
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

4. Figure 3
Flow chart of study selection. *Data which could not be integrated in this analysis were: (i) the proportion of patients having experienced at least one of a set of unpleasant consequences instead of one specific unpleasant consequence (Brinsden et al., 2000); (ii) the proportion of unpleasant consequences reported by a group of patients during one of multiple assessment points instead of a specific assessment point (Sharif et al., 1993), (iii) measures of central tendency (i.e. mode, mean or median) and variability (i.e. range or standard deviation) for a single Likert or numerical scale (e.g. Platteau et al., 2003). **Total of 34 papers, reporting on 35 studies as one paper actually reported on two separate studies (Porter et al., 2008).
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions